Finance
Food and animal safety products company reports third quarter results
Published in Immunotherapy Weekly, April 20th, 2005
The quarter, which ended Feb. 28, marks the 48th consecutive profitable quarter from operations for the company. Year-to-date, net income increased 11% to $4,471,000, or $0.53 per share from $0.48 in the prior year.
Year-to-date revenues for the first 9 months of Neogen's 2005 fiscal year were $46,748,000 - a 16% increase from $40,196,000 for the prior year's comparable period. Third quarter revenues were $14,403,000 compared to $14,717,000 in FY 2004.
"While I am proud to report that we remain solidly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2005-04-20)
More Articles from Immunotherapy Weekly
- Allergy and Immunology
Vaccine containing CpG oligodeoxynucleotides heighten immune activation - Arthritis
Inactivity due to arthritis does not cause obesity - Avian Viral Vaccines
RT-PCR used to detect reovirus contamination in avian viral vaccines - Rabies Vaccine
Adverse reactions to Thai Red Cross Society rabies vaccine reported - Vaccine Development
Predefined spacers between epitopes for vaccine development constructed - Acute Myeloid Leukemia
Criteria for defining complete remission re-evaluated - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
